Also known as Prandin
Repaglinide is an antidiabetic drug in the class of medications known as meglitinides, and was invented in 1983. It is sold by Novo Nordisk under the name of Prandin in the U.S., GlucoNorm in Canada, Surepost in Japan,Repaglinide in Egypt by EIPICO, and NovoNorm elsewhere. In Japan it is produced by Dainippon Sumitomo Pharma.Source: Wikipedia
Estimated Total Cost: $165.45 for an average of 28 days supply
Patients are most commonly prescribed repaglinide to treat diabetes, chronic kidney disease, acute kidney injury, and diabetic peripheral neuropathy.